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Rating Scale and its Observer Reliability 
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 Brain Imaging Research Centre, University of Edinburgh,  Edinburgh , UK 
demonstrating concomitant features of SVD such as lacunes 
and white matter hyperintensities. We rated basal ganglia, 
centrum semiovale, and midbrain PVS. Basal ganglia and 
centrum semiovale PVS were rated 0 (none), 1 (1–10), 2 (11–
20), 3 (21–40) and 4 (>40), and midbrain PVS were rated 0 
(none visible) or 1 (visible). We calculated kappa statistics for 
rating, assessed consistency in use of PVS categories (Bhap-
kar test) and reviewed sources of discrepancy.  Results: Intra- 
and inter-rater kappa statistics were highest for basal gan-
glia PVS (range 0.76–0.87 and 0.8–0.9, respectively) than for 
centrum semiovale PVS (range 0.68–0.75 and 0.61–0.8, re-
spectively) or midbrain PVS (inter-rater range 0.51–0.52). In-
ter-rater consistency was better for basal ganglia compared 
to centrum semiovale PVS (Bhapkar statistic 2.49–3.72, com-
pared to 6.79–21.08, respectively). Most inter-rater disagree-
ments were due to very faint PVS, coexisting extensive white 
matter hyperintensities (WMH) or the presence of lacunes. 
 Conclusions: We developed a more inclusive and robust vi-
sual PVS rating scale allowing rating of all grades of PVS se-
verity on structural brain imaging. The revised PVS rating 
scale has good observer reliability for basal ganglia and cen-
trum semiovale PVS, best for basal ganglia PVS, and moder-
ate reliability for midbrain PVS. Agreement is influenced by 
PVS severity and the presence of background features of 
SVD. The current scale can be used in further studies to as-
sess the clinical implications of PVS.  © 2015 S. Karger AG, Basel 
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 Abstract 
 Background: Perivascular spaces (PVS) are an important 
component of cerebral small vessel disease (SVD), several in-
flammatory disorders, hypertension and blood-brain barrier 
breakdown, but are difficult to quantify. A recent interna-
tional collaboration of SVD experts has highlighted the need 
for a robust, easy-to-use PVS rating scale for the effective in-
vestigation of the diagnostic and prognostic significance of 
PVS. The purpose of the current study was to develop and 
extend existing PVS scales to provide a more comprehensive 
scale for the measurement of PVS in the basal ganglia, cen-
trum semiovale and midbrain, and to test its intra- and inter-
rater agreement, assessing reasons for discrepancy.  Meth-
ods: We reviewed previously published PVS scales, including 
site of PVS assessed, rating method, and size and morpho-
logical criteria. Retaining key features, we devised a more 
comprehensive scale in order to improve the reliability of 
PVS rating. Two neuroradiologists tested the new scale in 
MRI brain scans of 60 patients from two studies (stroke, age-
ing population), chosen to represent a full range of PVS, and 
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 Introduction 
 Perivascular spaces (or Virchow-Robin spaces) sur-
round arterioles and venules as they perforate the brain 
parenchyma  [1] and are normally microscopic, but may 
be visualised on T2- or T1-weighted brain MRI when en-
larged ( fig. 1 ). PVS may act as drainage pathways to re-
move interstitial fluid from the brain  [2–4] , so, when en-
larged, may represent interstitial fluid trapped in the sub-
pial or interpial spaces  [5] . The full diagnostic and 
prognostic significance of PVS are unknown. PVS appear 
in small numbers in all age groups, but increase in fre-
quency with advancing age  [6, 7] , and are associated with 
worse cognition  [8–10] and with several disease states, 
including CADASIL (cerebral autosomal dominant arte-
riopathy with subcortical infarcts and leukoencephalopa-
thy)  [11] , depression at older ages  [12] , active multiple 
sclerosis during inflammation  [13] , myotonic dystrophy 
 [14] , Parkinson’s disease  [15] and small vessel disease 
(SVD) in the form of lacunar stroke  [16–20] , WMH  [18, 
20, 21] and vascular dementia  [22] .
 PVS form part of the spectrum of changes seen on MRI 
in SVD. Until recently, PVS have been somewhat ignored, 
not being included in any of the existing WMH rating 
scales  [23] . However, a recent international collaboration 
of experts in SVD has highlighted the need for a robust, 
easy-to-use PVS rating scale, alongside those in use for 
WMH and brain microbleeds  [24] . Reliable PVS rating 
scales, whether visual or automated  [24] are essential if the 
diagnostic and prognostic significance of PVS are to be 
investigated effectively. Several scales have been described 
(online suppl. table 1; for all online suppl. material, see 
www.karger.com/doi/10.1159/000375153)  [6, 8, 14, 18, 
22, 25–28] , but may not adequately capture the range of 
anatomical coverage, frequency or severity; these have not 
been extensively tested outside their inception studies. 
 The purpose of this study was to provide a more com-
prehensive scale and test its observer agreement, assess-
ing whether raters differed in their assessment of none, 
mild, moderate, frequent, and severe PVS in the presence 
of common features of aging and SVD. 
 Methods 
 We considered PVS to be small, sharply delineated structures of 
cerebrospinal fluid (CSF) intensity measuring <3 mm in cross-sec-
tional diameter, following the course of perforating vessels, round 
if in axial and longitudinal if cut in the long axis of the perivascular 
space  [24] . We reported the study according to the STRIVE guide-
lines. 
 Development and Extension of Existing PVS Rating Scales  
 We reviewed previously published scales (online suppl. table 1) 
 [6, 8, 14, 18, 22, 25–28] . A neuroradiologist applied each scale on 
two occasions to a test set of 20 standard T2-weighted MR scans 
from a study of aging, and made incremental modifications to one 
existing scale by carefully noting benefits and drawbacks of each 
scale as follows:
 PVS Sites 
 We retained basal ganglia and centrum semiovale regions (in-
cluded in all but one of the previously published scales; online sup-
pl. table  1) and added the midbrain (included in one previous 
scale), as these are three major sites for PVS  [1 ;  fig. 1 ] . We removed 
the hippocampus location because of its variable visualisation on 
axial images and because hippocampal PVS may be confused with 
hippocampal fissural cysts, currently thought to be normal vari-
ants. As most people have PVS in the anterior perforated substance 
 [26] , we chose not to add this location to the revised scale, for the 
basal ganglia, as it would not enhance specificity, although this has 
been included in a recently developed scale, in which PVS are as-
sessed on a single slice at the level of the anterior commissure  [28] . 
We did not separate PVS into sub-regions in the basal ganglia, as 
we found this difficult and time-consuming  [22] . Similarly, we 
found subgrouping of PVS in the centrum semiovale  [25] did not 
improve intra-rater variability. We tested the effects on intra-rater 
variability of using predefined slices and predefined regions, for 
example, for basal ganglia, using the slice showing the maximal 
area and for centrum semiovale, regions defined by predefined gyri 
and sulci, for instance, PVS anterior to the central sulcus. None of 
these improved consistency.
 Method of Rating 
 We retained the frequency and range of PVS used by Mac 
Lullich et al.  [8] as follows: 0 = none, 1 = 1–10, 2 = 11–20, 3 = 
21–40, 4 = >40 PVS per region ( fig. 2 ). These categories are simi-
lar to those used by Rouhl et al.  [25] and seemed to best reflect the 
potential frequency and range of PVS in a wide range of normal 
aging and stroke-related disease subjects; some previous scales 
had rather restricted range and frequency of PVS grades  [18, 22, 
27] or required every individual PVS to be counted  [14], and 
therefore, this was impractical for use in large studies and reduced 
reliability. 
 Size/Morphology 
 Unlike two previous studies  [14, 27] , we did not include size 
criteria due to difficulties in distinguishing between PVS measur-
ing <2 mm and 2–3 mm on routine images (this could be added in 
studies with very high-resolution images). We used frequency and 
range of PVS in preference to morphology. Although excluded in 
one previous scale  [25] , we chose to include PVS surrounded by a 
FLAIR-hyperintense rim, since the exact nature of these is unclear 
and we saw no reason to exclude them if they met PVS criteria in 
all other respects.
 PVS Rating Scale User Guide 
 We constructed a user guide with detailed definitions, descrip-
tions and clear examples (http://www.sbirc.ed.ac.uk/documents/
epvs-rating-scale-user-guide.pdf) prior to testing the revised scale, 
providing examples for each category/region with instructions on 
slice selection.
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 Fig. 1. Severe basal ganglia (top left) and 
centrum semiovale PVS (right). PVS visi-
ble in the midbrain (bottom left, arrow-
heads). 
 Fig. 2.  a  Grade 4 (severe) centrum semiovale PVS (highlighted in schematic).  b Grade 2 basal ganglia PVS (ar-
rowheads).  c Visible (grade 1) midbrain PVS (arrowheads). 
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 Assessment of Intra- and Inter-Rater Agreement of Revised 
PVS Rating Scale 
 Two experienced neuroradiologists (JMW, ZM), blinded to the 
other’s ratings and not involved in the initial testing of published 
scales or development of the revised scale, tested the modified PVS 
rating scale by each rating 60 T2-weighted MR scans (with T1-
weighted and FLAIR imaging also available), selected from the ar-
chives of the Brain Research Imaging Centre to represent a range 
of PVS, white matter hyperintensities and atrophy, from studies of 
ageing and minor stroke, on two separate occasions. For the basal 
ganglia and centrum semiovale PVS were rated from 0 (none), 1 
(1–10), 2 (11–20), 3 (21–40), and 4 (>40), using an overall score for 
both hemispheres by assessing and scoring each hemisphere sepa-
rately and then using the hemisphere with the higher score where 
hemispheres were asymmetric. Midbrain PVS were rated 0 (none 
visible) or 1 (visible). Images were reviewed by each rater in a ran-
dom order using a web-based random number service  (RANDOM.
ORG) on each occasion, at least one week apart. MRI scans were 
chosen to represent a range of few to many PVS from older subjects 
scanned in research studies on SVD at the Brain Research Imaging 
Centre and assessed digitally on a high-definition screen using the 
National Kodak Picture Archiving and Communication System. 
 Statistical Analysis 
 We calculated intra- and inter-observer weighted (quadratic) 
kappas for agreement beyond that due to chance for the basal gan-
glia and CS data and simple kappa for the midbrain data. All data 
were analysed with SAS 9.1 (www.sas.com), R 2.14.2 (cran.r- proj-
ect.org/), and MH Program 1.2 (www.john-uebersax.com/stat/
mh.htm). We also cross-tabulated PVS rating scores and provided 
the estimates of the overall percentage intra- and inter-rater agree-
ment, calculated by summing the number of times scans were giv-
en the same rating and dividing by the total number of scans. We 
assessed this percentage agreement for the overall score and for 
basal ganglia, centrum semiovale and midbrain PVS scores. 
 We also assessed the consistency of rating by whether raters 
differed in their assessment of PVS severity, both between the first 
and second scan assessment (intra-rater) and between raters (on 
the first assessment) using the Bhapkar  [29] test of the table ob-
tained by cross-tabulating the scan results.
 Results 
 Observer Agreement, Consistency of Rating and 
Sources of Discrepancy 
 Overall kappa statistic measurement of agreement for 
PVS was moderate to good. There was better agreement for 
basal ganglia PVS than for centrum semiovale PVS, with 
basal ganglia PVS intra- and inter-rater agreement ranging 
from 0.76 to 0.87 and from 0.8 to 0.9, compared to 0.68 to 
0.75 and 0.61 to 0.8 for centrum semiovale PVS, respec-
tively;  table  1 . Agreement was lowest for midbrain PVS, 
with intra-rater agreement ranging from 0.58 to 0.70 and 
inter-rater agreement ranging from 0.51 to 0.52 ( table 1 ).
 Overall, there was more intra-rater consistency (Bhap-
kar 0.34 to 18.2) than inter-rater consistency (Bhapkar 
2.49 to 21.08), and centrum semiovale PVS were rated less 
consistently than both basal ganglia and midbrain PVS 
(online suppl. tables 2, 3).
Table 1.  Intra- and inter-rater kappa statistics for PVS rating
Sample Brain region Rater Intra-rater kappa
(95% CI)
Inter-rater kappa**
(95% CI)
Aging study Centrum semiovale 1 0.68 (0.34–1.00) 0.61 (0.39–0.81)
2 0.70 (0.49–0.92)
Basal ganglia 1 0.80 (0.66–0.94) 0.80 (0.66–0.94)
2 0.76 (0.35–1.00)
Midbrain 1 0.64 (0.01–1.00) 0.51 (0.06–0.96)
2 0.58 (0.17–1.00)
Stroke study Centrum semiovale 1 0.75 (0.62–0.90) 0.80 (0.67–0.93)
2 0.74 (0.59–0.86)
Basal ganglia 1 0.87 (0.79–0.95) 0.90 (0.84–0.97)
2 0.80 (0.72–0.89)
Midbrain 1 0.60 (0.25–0.96) 0.52 (0.21–0.84)
2 0.79 (0.56–1.00)
 * Calculated using data from first rating.
** Kappa statistics for centrum semiovale and basal ganglia PVS quadratically weighted; quadratic weighting 
not possible for midbrain PVS due to only two possible categories for PVS rating.
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 Percentage Observer Agreement 
 For all PVS sites, intra-rater percentage agreement was 
similar to inter-rater agreement, ranging from 0.54 to 0.96 
compared to 0.43 to 0.87, respectively (online suppl. ta-
ble  4). Percentage agreement for basal ganglia and cen-
trum semiovale categories was similar, with intra- and in-
ter-observer agreement for basal ganglia ranging from 0.54 
to 0.68 and from 0.65 to 0.77, respectively and for centrum 
semiovale, from 0.57 to 0.65 and 0.65 to 0.68, respectively. 
Higher intra- and inter-rater percentage agreement was 
seen for midbrain PVS compared to both centrum semi-
ovale and basal ganglia PVS (supplementary table 4). 
 Discussion 
 A recent SVD expert collaborative highlights the 
emerging importance of PVS as an imaging marker for 
SVD on MRI. We reviewed existing PVS rating scales 
and developed a more inclusive and robust scale, incor-
porating all relevant PVS sites and allowing rating of all 
grades of PVS severity on standard structural brain MR 
imaging. We found good observer agreement between 
two experienced neuroradiologists for PVS rating in the 
centrum semiovale and basal ganglia, and moderate 
agreement for midbrain PVS. Kappa statistic measure-
ment of agreement and consistency of rating were better 
for basal ganglia than for centrum semiovale PVS, and 
lowest for midbrain PVS. Midbrain PVS agreement is 
likely to be artificially inflated by the limited number 
of PVS categories to choose from and the fewer number 
of slices on which midbrain PVS appear. The presence of 
concomitant WMH and lacunes were the main sources 
of discrepancy between observers (table 2, figure 3).
 The current scale was developed following a compre-
hensive review of existing PVS scales. We deliberately in-
cluded MRI scans range of background appearances, in-
cluding WMH and lacunes, which are more likely to re-
Table 2. Causes for intra-rater (a) and inter-rater (b) disagreement
a
PVS site Description n (%)
Centrum semiovale (n = 20) Asymmetric/focally dilated PVS 1 (5)
WMH presenta 7 (35)
No WMH presentb 11 (55)
Movement artefact 1 (5)
Basal ganglia (n = 8) Rating 2 versus 3, no clear cause for disagreement 6 (75)
Unilateral old large cortical infarct 1 (12.5)
Multiple possible lacunes bilaterally 1 (12.5)
a 1-point different in scale, n = 4; 2-point difference, n = 2; 3-point difference, n = 1.
WMH confluent (n = 5) or scattered (n = 2).
b 1-point difference in rating in 10/11 cases.
b
PVS site Description n (%)
Centrum semiovale (n = 21) WMH presenta 9 (42.9)
No WMH presentb 11 (52.4)
Movement artefact 1 (4.8)
Basal ganglia (n = 12) Rating 2 versus 3, no clear cause for disagreement 5 (41.7)
Unilateral old large cortical infarct 1 (12.5)
Multiple possible lacunesc 6 (50)
a 1-point different in scale, n = 6; 2-point difference, n = 3; WMH confluent (n = 7) or scattered (n = 2).
b 1-point difference in rating in 10/11 cases.
c Unilateral in 3, bilateral in 3.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
ity
 o
f E
di
nb
ur
gh
   
   
   
   
   
   
   
   
   
   
  
14
9.
12
6.
76
.9
7 
- 7
/2
7/
20
15
 5
:4
9:
16
 P
M
 Development of a Perivascular Space 
Rating Scale 
Cerebrovasc Dis 2015;39:224–231
DOI: 10.1159/000375153
229
flect the range of appearances likely to be seen in cohorts 
of older subjects and stroke patients in whom PVS scales 
are likely to be used. We included the three main sites 
where PVS are seen, rather than limiting assessment to 
restricted brain regions. We assessed PVS on commonly 
used structural MRI sequences, rather than specialised se-
quences, helping to increase its general applicability to 
current research studies of cerebral small vessel disease. 
We performed extensive, detailed multistatistical analysis 
of our data. 
 Our study had limitations. We did not assess atrophy, 
which may have an influence on PVS severity, but this 
was not the purpose of this study. The scale was tested by 
two experienced neuroradiologists, but brain imaging in 
many research studies is performed by non-radiologists 
 [27] and many raters may be less experienced in review-
ing MRI scans and in rating PVS. The use of two raters 
and experienced raters could have also led to inflated kap-
pa values. Other scales have used multiple observers; 
however in some cases, the type of rater, and experience 
in assessing MRI brain images, was unclear; our inclusion 
of a user guide is designed to help improve observer 
agreement among observers of difference background 
and experience. Our revised scale was tested in a cohort 
of healthy, elderly patients of a similar age and in a stroke 
cohort; therefore, our results may not be generalisable for 
all study populations. However, we acknowledge that 
more studies in larger and different populations are re-
quired.
 Our finding of lower intra- and inter-rater agreement 
for centrum semiovale PVS than for basal ganglia PVS 
confirms previous findings ( table 1 ). Higher overall intra- 
and inter-observer agreement for all brain regions de-
scribed by Patankar et al.  [22] may reflect the differences 
in imaging technique or less diseased subjects. We as-
sessed PVS on 5 mm thick contiguous structural brain 
MR imaging rather than on high-definition 3D sequenc-
es, and hence, our data may be more relevant to PVS in 
other cohorts ( table  1 ). Also high-definition sequences 
could increase observer disagreement by increasing the 
visibility of small PVS, which would need to be tested. The 
overall agreement was higher in all three brain regions in 
a recently developed PVS scale  [28] ; however, rating was 
performed on a single slice for the centrum semiovale and 
basal ganglia, which, although appearing more accurate, 
may not be a true or accurate reflection in number or se-
verity of PVS due to individual anatomical variation in 
the location of PVS, a factor further influenced by differ-
 Fig. 3. Main causes for observer variability in PVS rating.  a WMH in the centrum semiovale, with PVS still visible 
(left) or obscured (right).  b Small, poorly visualised PVS in the centrum semiovale (left) and basal ganglia (right). 
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ences in patient positioning. Our inter-rater data for bas-
al ganglia PVS are higher than that described by Rouhl et 
al.  [25] , with similar results for centrum semiovale PVS, 
which may reflect the differences in one or several factors, 
including type of observer, differences in background 
MRI brain appearances and method of PVS measure-
ment. 
 Greater variability in rating of centrum semiovale PVS 
may be partly due to the higher number of potential slic-
es available for rating, with slices containing more or less 
PVS depending on the level, or to WMH obscuring PVS; 
in the current study, concurrent WMH, especially when 
confluent, led to disagreement. PVS may still remain vis-
ible ‘through’ WMH. Others have selected only one rep-
resentative slice for the assessment of number of PVS in 
the hippocampus, basal ganglia, midbrain and centrum 
semiovale  [28] ; this may be oversimplification and prob-
lematic given the individual variability in position of PVS 
in the basal ganglia and centrum semiovale, and in our 
opinion, the assessment of all slices that include PVS in 
the brain region being assessed is necessary in order to 
form an overall impression of severity (or visibility, for 
midbrain). 
 At the present time, it is unclear whether increased se-
verity of PVS in a particular brain region has more impor-
tant clinical implications in the context of cerebral SVD 
 [20] ; however, until more data are available, assessment of 
PVS in each site is likely to be beneficial. Depending on 
future studies, our scale may require further modification, 
for example, the removal of centrum semiovale and mid-
brain locations, with a stronger focus on accurate rating 
of basal ganglia PVS. The clinical relevance of midbrain 
PVS is unclear at the present time; however, as this is a 
frequent site of PVS, it seems relevant to include this re-
gion. 
 Although we have developed and tested a visual rating 
scale, automated PVS measurement methods may be pos-
sible with improved image-processing algorithms in fu-
ture  [30] , as has already occurred for WMH rating  [31, 
32] , which may further improve consistency in rating.
 The clinical relevance of PVS is currently unclear. A 
recent international collaboration of SVD experts defin-
ing the terminology for imaging features of SVD high-
lights the need for a robust, easy-to-apply PVS rating 
scale, which can be used in multicenter research studies. 
We have developed a scale that enables the rating of PVS 
to a good level of inter-rater agreement for the two major 
PVS sites in the basal ganglia and centrum semiovale. 
This scale should be further tested in different patient 
populations and by raters with different clinical back-
grounds and imaging experience. Studies assessing the 
pathological role of PVS using such scales will need to 
consider other components of SVD in multivariable anal-
yses to account for the interrelationships between SVD 
features. 
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